Sinomenine hydrochloride-loaded dissolving microneedles enhanced its absorption in rabbits

References

• Shetty A, Hanson R, Korsten P, et al. Tocilizumab in the treatment of rheumatoid arthritis and beyond. Drug Des Dev Ther 2014;8:349–364
   PubMed Web of Science ®Google Scholar
• García-Hernández MH, González-Amaro R, Portales-Pérez DP. Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects. Immunotherapy 2014;6:623–636
   PubMed Web of Science ®Google Scholar
• Silva JC, Mariz HA, Rocha LF Jr, et al. Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clinics (Sao Paulo) 2013;68:766–771
   PubMed Web of Science ®Google Scholar
• Alam MK, Sutradhar SR, Pandit H, et al. Comparative study on methotrexate and hydroxychloroquine in the treatment of rheumatoid arthritis. Mymensingh Med J 2012;21:391–398
   PubMedGoogle Scholar
• Samara SA, Irshaid YM, Mustafa KN. Association of MDR1 C3435T and RFC1 G80A polymorphisms with methotrexate toxicity and response in Jordanian rheumatoid arthritis patients. Int J Clin Pharmacol Ther 2014;52:746–755
   PubMed Web of Science ®Google Scholar
• Sun Y, Yao Y, Ding CZ. A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines. Int Immunopharmacol 2014;18:135–141
   PubMed Web of Science ®Google Scholar
• Bird P, Griffiths H, Tymms K, et al. The SMILE study – safety of methotrexate in combination with leflunomide in rheumatoid arthritis. J Rheumatol 2013;40:228–235
   PubMed Web of Science ®Google Scholar
• Georgakopoulou EA, Achtari MD, Evangelou K, Kittas C. Oral non-Hodgkin’s lymphoma in a patient with rheumatoid arthritis treated with etanercept and methotrexate. J Clin Exp Dent 2015;7:180–182
   Google Scholar
• Fujibayashi T, Takahashi N, Kida D, et al. Comparable efficacy and safety between tacrolimus and methotrexate in combination with abatacept in patients with rheumatoid arthritis; a retrospective observational study in the TBC Registry. Mod Rheumatol 2015;16:1–19
   Google Scholar
• Vega IL. Methotrexate therapy for rheumatoid arthritis. Am Fam Physician 2015;91:26–27
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Takeuchi T, Yamanaka H, et al. Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study. Mod Rheumatol 2014;11:1–25
   Google Scholar
• Rau R. Glucocorticoid treatment in rheumatoid arthritis. Expert Opin Pharmacother 2014;15:1575–1583
   PubMed Web of Science ®Google Scholar
• Xu M, Liu L, Qi C, et al. Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Planta Med 2008;74:1423–1429
   PubMed Web of Science ®Google Scholar
• Liu L, Resch K, Kaever V. Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine. Int Immunopharmacol 1994;16:685–691
   PubMed Web of Science ®Google Scholar
• Liu L, Buchner E, Beitze D, et al. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int Immunopharmacol 1996;18:529–543
   PubMed Web of Science ®Google Scholar
• Feng H, Yamaki K, Takano H, et al. Effect of sinomenine on collagen-induced arthritis in mice. Autoimmunity 2007;40:532–539
   PubMed Web of Science ®Google Scholar
• Sun Y, Yao Y, Ding CZ. A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines. Int Immunopharmacol 2014;18:135–141
   PubMed Web of Science ®Google Scholar
• Mark W, Schneeberger S, Seiler R, et al. Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection. Transplantation 2003;75:940–945
   PubMed Web of Science ®Google Scholar
• Zhao Y, Li J, Yu K, et al. Sinomenine inhibits maturation of monocyte-derived dendritic cells through blocking activation of NF-kappa B. Int Immunopharmacol 2007;7:637–645
   PubMed Web of Science ®Google Scholar
• Gao T, Hao J, Wiesenfeld-Hallin Z, et al. Analgesic effect of sinomenine in rodents after inflammation and nerve injury. Eur J Pharmacol 2013;721:5–11
   PubMed Web of Science ®Google Scholar
• Huang ZX, Tan JH, Li TW, et al. Influence of sinomenine on protein profiles of peripheral blood mononuclear cells from ankylosing spondylitis patients: a pharmacoproteomics study. Chinese Med J 2013;126:3645–3650
   PubMed Web of Science ®Google Scholar
• Wang MH, Chang CK, Cheng JH, et al. Activation of opioid mu-receptor by sinomenine in cell and mice. Neurosci Lett 2008;443:209–212
   PubMed Web of Science ®Google Scholar
• Chen SW, Mi XJ, Wang R, et al. Behavioral effects of sinomenine in murine models of anxiety. Life Sci 2005;78:232–238
   PubMed Web of Science ®Google Scholar
• Teng P, Liu HL, Zhang L, et al. Synthesis and biological evaluation of novel sinomenine derivatives as anti-inflammatory agents. Eur J Med Chem 2012;50:63–74
   PubMed Web of Science ®Google Scholar
• Zhang MF, Zhao Y, Jiang KY, et al. Comparative pharmacokinetics study of sinomenine in rats after oral administration of sinomenine monomer and sinomenium acutum extract. Molecules 2014;19:12065–12077
   PubMed Web of Science ®Google Scholar
• Alexander A, Dwivedi S, Giri TK, et al. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release 2012;164:26–40
   PubMed Web of Science ®Google Scholar
• Mitragotri S. Devices for overcoming biological barriers: the use of physical forces to disrupt the barriers. Adv Drug Deliv Rev 2013;65:100–103
   PubMed Web of Science ®Google Scholar
• Tao SL, Desai TA. Microfabricated drug delivery systems: from particles to pores. Adv Drug Deliv Rev 2003;55:315–328
   PubMed Web of Science ®Google Scholar
• Tuan-Mahmood TM, McCrudden MT, Torrisi BM, et al. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci 2013;50:623–637
   PubMed Web of Science ®Google Scholar
• Van der Maaden K, Jiskoot W, Bouwstra J. Microneedle technologies for transdermal drug and vaccine delivery. J Control Release 2012;161:645–655
   PubMed Web of Science ®Google Scholar
• Vrdoljak A, McGrath MG, Carey JB, et al. Coated microneedle arrays for transcutaneous delivery of live virus vaccines. J Control Release 2012;159:34–42
   PubMed Web of Science ®Google Scholar
• Martin CJ, Allender CJ, Brain KR, et al. Low temperature fabrication of biodegradable sugar glass microneedles for transdermal drug delivery applications. J Control Release 2012;158:93–101
   PubMed Web of Science ®Google Scholar
• Kim YC, Yoo DG, Compans RW, et al. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles. J Control Release 2013;172:579–588
   PubMed Web of Science ®Google Scholar
• Chong RH, Gonzalez-Gonzalez E, Lara MF, et al. Gene silencing following siRNA delivery to skin via coated steel microneedles: in vitro and in vivo proof-of-concept. J Control Release 2013;166:211–219
   PubMed Web of Science ®Google Scholar
• Matsuo K, Yokota Y, Zhai Y, et al. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens. J Control Release 2012;161:10–17
   PubMed Web of Science ®Google Scholar
• Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 2012;64:1547–1568
   PubMed Web of Science ®Google Scholar
• Park JH, Choi SO, Seo S, et al. A microneedle roller for transdermal drug delivery. Eur J Pharm Biopharm 2010;76:282–289
   PubMed Web of Science ®Google Scholar
• Kim M, Jung B, Park JH. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin. Biomaterials 2012;33:668–678
   PubMed Web of Science ®Google Scholar
• Lee K, Lee CY, Jung H. Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose. Biomaterials 2011;32:3134–3140
   PubMed Web of Science ®Google Scholar
• Kolli CS, Banga AK. Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm Res 2008;25:104–113
   PubMed Web of Science ®Google Scholar
• Li G, Badkar A, Nema S, et al. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int J Pharm 2009;368:109–115
   PubMed Web of Science ®Google Scholar
• Mahapatro A, Singh DK. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnol 2011;9:55. doi: 10.1186/1477-3155-9-55
   PubMed Web of Science ®Google Scholar
• Kumar A, Wonganan P, Sandoval MA, et al. Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles. J Control Release 2012;163:230–239
   PubMed Web of Science ®Google Scholar
• Lee K, Lee CY, Jung H. Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose. Biomaterials 2011;32:3134–3140
   PubMed Web of Science ®Google Scholar
• Garland MJ, Migalska K, Tuan-Mahmood TM, et al. Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays. Int J Pharm 2012;434:80–89
   PubMed Web of Science ®Google Scholar
• Qian SS, Chen YL, Gui SY, et al. Enhanced penetration of sinomenine fomulations following skin pretreatment with a polymer microneedle patch. Lat Am J Pharmacy 2014;33:464–469
   Web of Science ®Google Scholar
• Parker R, Ring SG. Diffusion in maltose–water mixtures at temperatures close to the glass transition. Carbohyd Res 1995;273:147–155
   Web of Science ®Google Scholar
• Gentile P, Chiono V, Carmagnola I, Hatton PV. An overview of poly(lactic-co-glycolic)acid (PLGA)-based biomaterials for bone tissue engineering. Int J Mol Sci 2014;15:3640–3659
   PubMed Web of Science ®Google Scholar
• Zhao L, Wu C, Lin K, Chang J. The effect of poly (lactic-co-glycolic acid) (PLGA) coating on the mechanical, biodegradable, bioactive properties and drug release of porous calcium silicate scaffolds. Biomed Mater Eng 2012;22:289–300
   PubMed Web of Science ®Google Scholar
• Ito Y, Yamazaki T, Sugioka N, et al. Self-dissolving micropile array tips for percutaneous administration of insulin. J Mater Sci Mater Med 2010;21:835–841
   PubMed Web of Science ®Google Scholar
• Fukushima K, Ise A, Morita H, et al. Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats. Pharm Res 2011;28:7–21
   PubMed Web of Science ®Google Scholar
• Song J, Bi H, Xie X, et al. Preparation and evaluation of sinomenine hydrochloride in situ gel for uveitis treatment. Int Immunopharmacol 2013;17:99–107
   PubMed Web of Science ®Google Scholar
• Ling JJ, Wang Y, Xie B, Zhou LL. Bioequivalence study of sinomenine patch by microdialysis. Zhongguo Zhong Yao Za Zhi 2008;33:2482–2485 (in Chinese)
   PubMedGoogle Scholar
• Ba W, Li Z, Wang L, et al. Optimization and evaluation of pluronic lecithin organogels as a transdermal delivery vehicle for sinomenine. Pharm Dev Technol 2015. [Epub ahead of print]. doi: 10.3109/10837450.2015.1022791
   PubMed Web of Science ®Google Scholar
• Lee JW, Han MR, Park JH. Polymer microneedles for transdermal drug delivery. J Drug Target 2013;21:211–223
   PubMed Web of Science ®Google Scholar
• Matsuo K, Yokota Y, Zhai Y, et al. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens. J Control Release 2012;161:10–17
   PubMed Web of Science ®Google Scholar
• Ito Y, Hamasaki N, Higashino H, et al. Method to microneedles for drug delivery increase the systemically delivered amount of drug from dissolving microneedles. Chem Pharm Bull 2013;61:8–15
   PubMed Web of Science ®Google Scholar
• Lee JW, Park JH, Prausnitz MR. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008;29:2113–2124
   PubMed Web of Science ®Google Scholar
• Cleary GW. Microneedles for drug delivery. Pharm Res 2011;28:1–6
   PubMed Web of Science ®Google Scholar
• Kalluri H, Banga AK. Formation and closure of microchannels in skin following microporation. Pharm Res 2011;28:82–94
   PubMed Web of Science ®Google Scholar
• Ke CJ, Lin YJ, Hu YC, et al. Multidrug release based on microneedle arrays filled with pH-responsive PLGA hollow microspheres. Biomaterials 2012;33:5156–5165
   PubMed Web of Science ®Google Scholar
• Park JH, Choi SO, Kamath R, et al. Polymer particle-based micromolding to fabricate novel microstructures. Biomed Microdev 2007;9:223–234
   PubMed Web of Science ®Google Scholar
• Ito Y, Ise A, Sugika N, Takada K. Molecular weight dependence on bioavailability of FITC-dextran after administration of self-dissolving micropile to rat skin. Drug Dev Ind Pharm 2010;36:845–851
   PubMed Web of Science ®Google Scholar
• Ito Y, Kashiwara S, Fukushima K, Takada K. Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats. Drug Dev Ind Pharm 2011;37:1387–1393
   PubMed Web of Science ®Google Scholar
• Ito Y, Maeda T, Fukushima K, et al. Permeation enhancement of ascorbic acid by self-dissolving micropile array tip through rat skin. Chem Pharm Bull (Tokyo) 2010;58:458–463
   PubMed Web of Science ®Google Scholar
• Lee JW, Choi SO, Felner EI, Prausnitz MR. Dissolving microneedle patch for transdermal delivery of human growth hormone. Small 2011;7:531–539
   PubMed Web of Science ®Google Scholar
• Sullivan SP, Koutsonanos DG, Del Pilar Martin M, et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med 2010;16:915–920
   PubMed Web of Science ®Google Scholar